Adolescents and HIV Vaccine Trials
- 1 October 2005
- journal article
- research article
- Published by SAGE Publications in Journal of the International Association of Physicians in AIDS Care
- Vol. 4 (4) , 93-97
Abstract
Adolescents worldwide are at high risk for HIV, which makes them essential candidates for HIV vaccine trials. However, enrollment of adolescents into such trials has implications for trial sites. Adolescents are considered vulnerable subjects and require proxy consent in addition to their assent, which brings issues of confidentiality and access into play. HIV vaccine trial sites often do not have experience recruiting and retaining adolescents, and creating youth-friendly environments that are comfortable for guardians. This includes development of education materials that target both youth and their parents. Because these trials are of minimal individual benefit, sites will likely need to provide service in the form of health care and supportive structures to adolescents. Finally, a number of trial design options exist, and researchers will need to balance the risks and benefits of each, as for all issues surrounding the involvement of adolescents in HIV vaccine trials.Keywords
This publication has 6 references indexed in Scilit:
- Challenges to Conducting HIV Preventative Vaccine Trials With AdolescentsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2004
- HIV Vaccines in Infants and Children: Past Trials, Present Plans and Future PerspectivesCurrent Molecular Medicine, 2003
- Recruitment and Retention of Adolescent Participants in HIV Research: Findings From the REACH (Reaching for Excellence in Adolescent Care and Health) ProjectJournal of Adolescent Health, 2003
- Unsafe sexual behaviour in South African youthSocial Science & Medicine, 2003
- Violence, rape, and sexual coercion: Ever yday love in a South African townshipGender & Development, 1997
- Drug Use, Attitudes, and Behaviors of Youth in an Urban Free ClinicInternational Journal of the Addictions, 1978